Dr. Oz jumps in as drug exec collapses during Oval Office press conference

Drug Executive Collapses During Oval Office Press Conference

A drug executive fainted in the Oval Office while President Donald Trump announced a deal with drugmakers to lower obesity drug prices. The event, involving representatives from Eli Lilly and Novo Nordisk, was cut short on Thursday.

Incident Details

During the press conference about the deal to expand coverage and reduce prices for obesity treatments Zepbound and Wegovy, Gordon Findlay, Novo Nordisk's global brand director, collapsed.

David Ricks, Eli Lilly's CEO, asked, "Are you okay? Gordon, are you okay?"

Dr. Mehmet Oz quickly intervened as Findlay fell to his knees. The press was then asked to leave the room.

Officials Present and Response

Follow-up

About 30 minutes later, the press conference resumed, and President Trump provided an update on the executive's condition.

“The press conference was interrupted when a drug executive fainted,” the President said, noting the concern for his health.

Author's summary: A drug executive's fainting during a White House event highlighted the high-profile effort to reduce obesity drug prices involving President Trump and major pharmaceutical companies.

more

FOX 4 News Dallas-Fort Worth FOX 4 News Dallas-Fort Worth — 2025-11-06

More News